Random choices, permutations and timing of vendors will make it difficult to determine cause and effect. No control groups. If there are future adverse events, they may be attributed to a specific human rather than a cohort of peers.
This could justify more observational surveillance and testing, laying the groundwork for future personalized treatments, including unique vaccines. In that hypothetical scenario, rare injuries could lead to more live trials on those humans.
This could justify more observational surveillance and testing, laying the groundwork for future personalized treatments, including unique vaccines. In that hypothetical scenario, rare injuries could lead to more live trials on those humans.